ATP6AP1-CDG: Follow-up and female phenotype

Patryk Lipiński1, Dariusz Rokicki1, Anna Bogdańska2

  • 1Department of Pediatrics, Nutrition and Metabolic Diseases The Children's Memorial Health Institute Warsaw Poland.

JIMD Reports
|May 13, 2020
PubMed

Insights

X-linked ATP6AP1 deficiency causes severe immunodeficiency and multi-organ disease. This study tracks disease progression, including hearing loss and alopecia, in affected siblings and carriers.

Area of Science:

  • Genetics
  • Immunology
  • Metabolic disorders

Background:

  • X-linked ATP6AP1 deficiency (ATP6AP1-CDG) presents with immunodeficiency, hepatic, gastric, and neurological issues.
  • Previous reports detailed additional features like connective tissue abnormalities, hearing loss, and metabolic dysfunction.

Purpose of the Study:

  • To describe the long-term follow-up and disease progression in siblings with ATP6AP1-CDG.
  • To investigate potential clinical manifestations in female carriers of ATP6AP1-CDG.

Main Methods:

  • Longitudinal clinical observation of three affected siblings.
  • Clinical evaluation of three female carriers, including serum transferrin isoelectric focusing and urinalysis.

Main Results:

  • Siblings exhibited progressive sensorineural hearing loss to total deafness, hair loss (alopecia), skin changes, and proteinuria.
  • Female carriers showed normal serum transferrin isoelectric focusing, but two developed persistent proteinuria.

Conclusions:

  • ATP6AP1-CDG is a progressive disorder with significant multi-systemic impact.
  • Proteinuria may be a manifestation in both affected males and female carriers, warranting further investigation.